ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 176328 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 176328; 2) Community: the network communities that were significantly associated with the response to NSC 176328; 3) Molecule: the relationships between components within communities and NSC 176328; 4) MDR: the compounds that were significantly associated with the NSC 176328.

NSC Compound Enrichment Correlation
NSC 718781 Erlotinib hydrochloride 0.029142074732756 -0.22226711
NSC 724783 [1,5-dimethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetra cyclo[10.3.1.04,13.08,13]hexadec-9-en-9-yl]-N,N-bis{[1,5-dim ethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetracyclo[10 .3.1.04,13.08,13 0.029142074732756 0.11880428
NSC 725098 Null 0.029142074732756 0.37326965
NSC 726217 Combretastatin A4-analogue 0.029142074732756 0.42316454
NSC 733149 Null 0.029142074732756 0.30301609
NSC 735472 (2E,8S,9Z)-2,9,16-heptadecatrien-4,6-diyn-1,8-diol 0.029142074732756 0.076813239
NSC 743433 8-(4-{4-[6-(4-piperazinoquinazoline)-7-methoxy-2,3,5,11-atetrahydra-1H-benzo[e]pyrrolo[1,2-c][1,4]diazepin-5-one 0.029142074732756 0.26513052
NSC 743695 Null 0.029142074732756 0.18361547
NSC 744688 Null 0.029142074732756 0.35027852
NSC 749169 8H-thieno[2'3':4,5]pyrimido[2,1-a]phthalazin-8-one,5-[[3-(dimethylamino)propyl]amino]-9,10-dimethyl 0.029142074732756 0.32736274
Total:145  Current:109    [First] [Prev] [Next] [Last]